Hong Kong stocks surge | Hipray (09989.HK) rises by more than 3% in the morning. Recently received approval notification from EMA for the addition of a new manufacturer of enoxaparin sodium injection.

According to the Securities Times APP, Hepu Ray (09989.HK) rose more than 3% in the morning, as of the time of publication, it rose by 3.09% to 5.33 Hong Kong dollars, with a turnover of 8.72 million Hong Kong dollars.